GGrantIndex
Sort

40,608 grants matching prostate cancer

Analysis of Tumor Dynamics in Progression and Metastasis

$543,220
University Of Pennsylvania · U01 · FY2005 · CA

Targeting chemoresistant prostate cancer with novel EED inhibitors

$543,181
Daqing Wu · Clark Atlanta University · R01 · FY2022 · CA

Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate Cancer

$543,161
Eric H Kim · Washington University · R01 · FY2022 · CA

Enhancing Native American Participation in RT Trials

$543,034
Daniel G Petereit · Rapid City Regional Hospital · U56 · FY2007 · CA

Nitric Oxide as a Modifier of Oxidative Stress

$542,980
David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA

DEVELOPMENT OF RECTAL NEAR INFRARED SCANNING POLARIZATION IMAGING UNIT & INDEPENDENT COMPONENT ANALYSIS ALGORITHM FOR PROSTATE CANCER DETECTION

$542,940
Research Foundation Of The City University Of New York · · FY2008 · Department of the Army

Pathogenesis of human prostate carcinomas

$542,890
Pradip Roy-Burman · University Of Southern California · R01 · FY2007 · CA

A LABEL-FREE AND CHEMICAL-SELEVTIVE MICROENDOSCOPE TO ENHANCE PROSTATE CANCER SURGICAL OUTCOMES

$542,857
The Methodist Hospital Research Institute · · FY2012 · Department of Defense

Decision Navigation for Advanced Prostate Cancer Treatment Options using mHealth

$542,846
Randy Allen Jones · University Of Virginia · R01 · FY2020 · NR

Targeting mechanisms of radiation resistance

$542,797
Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Race, Prostate Cancer Treatment, and Treatment Decision Difficulty and Regret

$542,725
Willie Underwood · Roswell Park Cancer Institute Corp · R01 · FY2014 · CA

Whitlockite nanoparticle-based immunotherapy for bone metastasis

$542,721
Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2021 · CA

Examining the Relationship between Residential History at Midlife and Prostate Cancer Outcomes

$542,620
Charnita M Zeigler-Johnson · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · MD

COHORT MANAGEMENT

$542,610
Patricia L Blount · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA

15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi

$542,530
Li Li · Case Western Reserve University · U01 · FY2015 · CA

Patient-Clinician Information Exchange: Determinants and Effects on Health Behavi

$542,486
Robert C. Hornik · University Of Pennsylvania · P20 · FY2011 · CA

Administrative Core

$542,454
Shafiq A Khan · Clark Atlanta University · U54 · FY2020 · MD

Small molecule probes of MYC stability and function intumorigenesis

$542,383
Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2024 · CA

Targeting apoptotic cells to enhance radiotherapy

$542,350
Jianghong Rao · Stanford University · R01 · FY2024 · CA

NONINVASIVE RISK STRATIFICATION OF PROSTATE CANCER PATIENTS USING RADIOMIC FEATURES DERIVED FROM MAGNETIC RESONANCE FINGERPRINTING (MRF) AND MRI

$542,293
Case Western Reserve University · · FY2018 · Department of the Army

Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance

$542,286
Antonio Fojo · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA

Cancer Center Support Grant

$542,255
Alan Ashworth · University Of California, San Francisco · P30 · FY2015 · CA

PALS: Prostate Cancer Active Lifestyle Study

$542,196
Jonathan L. Wright · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA

A kit based PET agent: edotreotide Ga 68 for clinical imaging of somatostatin rec

$542,102
James F Kronauge · Molecular Insight Pharmaceuticals, Inc. · R44 · FY2012 · CA

Study the role(s) of p53 in embryonic stem cells

$542,071
Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA